azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel]
- RxCUI
- 1145112
- RxNorm name
- azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-06-17 07:05:11
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092011
- Active start
- 092011
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 10 MG / 1 EACH | zinc oxide | ||
| 1.5 MG / 1 EACH | cupric oxide | ||
| 500 MCG / 1 EACH | folic acid | ||
| 5 MG / 1 EACH | azelate | ||
| 5 MG / 1 EACH | pyridoxine | ||
| 600 MG / 1 EACH | niacinamide |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| zinc oxide | 11423 |
| cupric oxide | 21837 |
| folic acid | 4511 |
| azelate | 618278 |
| pyridoxine | 684879 |
| niacinamide | 7405 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel] | NAMES |
| RxNorm Name | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel] | NAMES |
| TTY | SBDC | ATTRIBUTES |
| RxCUI | 1145112 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | B03BB | Folic acid and derivatives | ATC1-4 | folic acid | |
| ATC | D10AX | Other anti-acne preparations for topical use | ATC1-4 | azelaic acid | |
| ATC | V04CX | Other diagnostic agents | ATC1-4 | folic acid | |
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | niacinamide | |
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | pyridoxine | |
| FDASPL | D025101 | Vitamin B 6 | CHEM | has_chemical_structure | pyridoxine |
| FDASPL | N0000192800 | Vitamin B6 Analog | EPC | has_epc | pyridoxine |
| FDASPL | N0000008841 | Decreased Protein Synthesis | PE | has_pe | azelaic acid |
| FDASPL | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | azelaic acid |
| MEDRT | D003300 | Copper | CHEM | has_ingredient | cupric oxide |
| MEDRT | D003998 | Dicarboxylic Acids | CHEM | has_ingredient | azelaic acid |
| MEDRT | D005492 | Folic Acid | CHEM | has_ingredient | folic acid |
| MEDRT | D009536 | Niacinamide | CHEM | has_ingredient | niacinamide |
| MEDRT | D011736 | Pyridoxine | CHEM | has_ingredient | pyridoxine |
| MEDRT | D015034 | Zinc Oxide | CHEM | has_ingredient | zinc oxide |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | azelaic acid |
| MEDRT | D000741 | Anemia, Aplastic | DISEASE | ci_with | folic acid |
| MEDRT | D018798 | Anemia, Iron-Deficiency | DISEASE | ci_with | folic acid |
| MEDRT | D000749 | Anemia, Megaloblastic | DISEASE | may_treat | folic acid |
| MEDRT | D000752 | Anemia, Pernicious | DISEASE | ci_with | folic acid |
| MEDRT | D019080 | Cafe-au-Lait Spots | DISEASE | may_prevent | zinc oxide |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_prevent | niacinamide |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | zinc oxide |
| MEDRT | D003963 | Diaper Rash | DISEASE | may_treat | zinc oxide |
| MEDRT | D003967 | Diarrhea | DISEASE | induces | niacinamide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | azelaic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | zinc oxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | folic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pyridoxine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | niacinamide |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | pyridoxine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | pyridoxine |
| MEDRT | D004485 | Eczema | DISEASE | may_treat | zinc oxide |
| MEDRT | D005414 | Flatulence | DISEASE | induces | niacinamide |
| MEDRT | D005483 | Flushing | DISEASE | induces | niacinamide |
| MEDRT | D005494 | Folic Acid Deficiency | DISEASE | may_prevent | folic acid |
| MEDRT | D005494 | Folic Acid Deficiency | DISEASE | may_treat | folic acid |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | niacinamide |
| MEDRT | D006937 | Hypercholesterolemia | DISEASE | may_treat | niacinamide |
| MEDRT | D015228 | Hypertriglyceridemia | DISEASE | may_treat | niacinamide |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | niacinamide |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | niacinamide |
| MEDRT | D009436 | Neural Tube Defects | DISEASE | may_prevent | folic acid |
| MEDRT | D009750 | Nutritional and Metabolic Diseases | DISEASE | may_treat | cupric oxide |
| MEDRT | D009750 | Nutritional and Metabolic Diseases | DISEASE | may_prevent | cupric oxide |
| MEDRT | D010383 | Pellagra | DISEASE | may_treat | niacinamide |
| MEDRT | D010383 | Pellagra | DISEASE | may_prevent | niacinamide |
| MEDRT | D010437 | Peptic Ulcer | DISEASE | ci_with | niacinamide |
| MEDRT | D016491 | Peripheral Vascular Diseases | DISEASE | may_treat | niacinamide |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | cupric oxide |
| MEDRT | D012393 | Rosacea | DISEASE | may_treat | azelaic acid |
| MEDRT | D012640 | Seizures | DISEASE | may_treat | pyridoxine |
| MEDRT | D012878 | Skin Neoplasms | DISEASE | may_prevent | zinc oxide |
| MEDRT | D013471 | Sunburn | DISEASE | may_prevent | zinc oxide |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_treat | pyridoxine |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_prevent | pyridoxine |
| MEDRT | D014947 | Wounds and Injuries | DISEASE | may_treat | zinc oxide |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | cupric oxide |
| MEDRT | N0000000231 | Enzyme Activators | MOA | has_moa | niacinamide |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | folic acid |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | pyridoxine |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | niacinamide |
| MEDRT | N0000000065 | Physiochemical Activity | MOA | has_moa | zinc oxide |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | azelaic acid |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | niacinamide |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | folic acid |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | pyridoxine |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | cupric oxide |
| MEDRT | N0000008555 | Decreased Cholesterol Synthesis | PE | has_pe | niacinamide |
| MEDRT | N0000008687 | Decreased Lipogenesis | PE | has_pe | niacinamide |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | azelaic acid |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | azelaic acid |
| MEDRT | N0000009061 | Glucose Metabolism Alteration | PE | has_pe | niacinamide |
| MEDRT | N0000009345 | Increased Glycogenolysis | PE | has_pe | niacinamide |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | niacinamide |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | niacinamide |
| MEDRT | N0000009881 | Sunscreening Activity | PE | has_pe | zinc oxide |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SBDC |
| CODES | RxCUI | 1145112 |
| NAMES | RXNAV_STR | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel] |
| NAMES | RxNorm Name | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [NicAzel] |